ARMETHEON
Armetheon, Inc., is a privately held San Francisco Bay area based clinical stage biopharmaceutical company focused on the development of novel drugs for highly unmet need. The company has several programs in clinical stage of development. These include:
ARMETHEON
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2011-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.armetheon.com
Total Employee:
11+
Status:
Closed
Contact:
(650) 646-3898
Email Addresses:
[email protected]
Total Funding:
31.3 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Maps ReCAPTCHA Nginx U.S. Server Location Google Maps API DoubleClick.Net CloudFront
Current Employees Featured
Founder
Investors List
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Series B - Armetheon
Atheneos Ventures
Atheneos Ventures investment in Series B - Armetheon
CDIB Capital
CDIB Capital investment in Series B - Armetheon
Capital TEN
Capital TEN investment in Series B - Armetheon
Larry Hsu
Larry Hsu investment in Series A - Armetheon
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Series A - Armetheon
AshHill Biomedical
AshHill Biomedical investment in Series A - Armetheon
Atheneos Ventures
Atheneos Ventures investment in Series A - Armetheon
Official Site Inspections
http://www.armetheon.com
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney
More informations about "Armetheon"
Armetheon 2025 Company Profile: Valuation, Investors ... - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for Armetheon. Use the PitchBook Platform to explore the full profile.See details»
Armetheon - Crunchbase Company Profile & Funding
Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.See details»
Armetheon - LinkedIn
Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company. In Q3, 2017, Armetheon merged with Espero Pharmaceuticals, Inc to become Espero BioPharma, Inc, a ...See details»
Organization | Armetheon Inc
Armetheon Inc Report issue For profit Phase 3 Founded: Menlo Park CA United States (2011) Status: Acquired by Espero BioPharma (2017)See details»
Armetheon - VentureRadar
"Armetheon, Inc. is a privately held San Francisco Bay area based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases.See details»
Armetheon - Products, Competitors, Financials, Employees, …
Armetheon is a privately held San Francisco Bay area based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. Use the CB …See details»
Armetheon Information - RocketReach
Armetheon is a Pharmaceutical Manufacturing, Pharmaceuticals, and Drug Development company located in Santa Clara, California with $8.4 million in revenue and 1 employees. Find …See details»
Armetheon - Company Profile - Tracxn
Feb 18, 2025 Armetheon is a clinical stage company focussed on developing small molecule therapies for cardiovascular disorders. Its lead candidate tecarfarin is a long-acting inhibitor of …See details»
Armetheon Inc - Company Profile and News - Bloomberg Markets
Company profile page for Armetheon Inc including stock price, company news, executives, board members, and contact informationSee details»
Armetheon, Inc.:Company Profile & Technical …
Armetheon, Inc. is a company that provides Biopharmaceutical, Medicine, Anticoagulant and more. Armetheon, Inc. is headquartered in United States California. Armetheon, Inc. was …See details»
Armetheon Inc Company Profile, Financial and Strategic SWOT
Armetheon, Inc., a biopharmaceutical company, focuses on the development of novel anticoagulants and novel antibiotics. Its products include tecarfarin, a lead drug candidate for …See details»
Armetheon, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore Armetheon, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature, Technology Platform:Small molecule drug, Drug ...See details»
Armetheon Overview | SignalHire Company Profile
Summary Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company. In Q3, 2017, Armetheon merged with Espero Pharmaceuticals, Inc to become …See details»
Armetheon | VentureRadar
Armetheon, Inc. is a privately held San Francisco Bay area based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases.See details»
Armetheon | Startup Profile and Investments - Bounce Watch
Armetheon is a San Francisco Bay-based clinical stage biopharmaceutical company founded in 2011. Committed to addressing urgent medical needs, the company focuses on pioneering …See details»
Armetheon, Inc. Appoints John F. Glenn As Chief Financial Officer
Feb 20, 2015 Armetheon, Inc., is a privately held, San Francisco Bay area-based specialty biopharmaceutical company focused on developing novel small molecule drugs for …See details»
Armetheon - Funding, Financials, Valuation & Investors
Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.See details»
Armetheon - buildingbetterhealthcare.com
Through digital, live and print products, Building Better Healthcare informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors …See details»
About Our Company - Amatheon
Our mission is to equip veterinarians with the medications and support they need to deliver high-quality care, helping companion animals stay active and well.See details»
Armetheon - Profiles & Contacts - Crunchbase
Armetheon is a cardiovascular focused late-clinical stage specialty pharmaceutical company.See details»